Each study was systematically reviewed and categorized based on its design, outcomes, and interventions
A recent network meta-analysis suggested that GLP-1R agonists were associated with significantly greater activity in decreasing liver fat content and improving cardiometabolic risk parameters in overweight or obese patients with NAFLD vs
Examining differences between overweight women and men in 12-month weight loss study comparing healthy low-carbohydrate vs
I am no longer surprised when providers dont declare me ineligible for medication based on my BMI, as it seems most providers these days do not have a BMI minimum, which can be good and bad
(2024) Semaglutide and cardiovascular outcomes in obesity without diabetes: Results from the SELECT trial, Journal of the American College of Cardiology, 84(10), pp
If you see any of the following, do not use the product